4500 Boulevard Kimber
Suite 26
Saint-Hubert, QC J3Y 8K5
Canada
866 722 2442
http://www.lumiera.ca
Sector(s):Â Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees:Â
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Mario Paradis | CFO, Interim CEO & Director | N/A | N/A | N/A |
Mr. Jamil Samsatly Ph.D. | Chief Scientific Officer | N/A | N/A | N/A |
Lumiera Health Inc. develops and commercializes evidence-based botanical products for the healthcare, bio-agriculture, and organic markets in Canada. It is developing botanical based specialty fertilizers for enhancing plant growth and crop yield; botanical agents to prevent and treat fungal infections of plants; oral and topical botanical agents to manage unmet medical needs, such as fungal infections of nails and skin, women's health, dermatology, and sleep; natural bio stimulants, bio fertilizers, and bio pesticides; specialty fertilizers for use in household plants, lawns and golf courses, urban gardens, nurseries, commercial greenhouses, and indoor cannabis growers; and products for acne and wound healing. The company was formerly known as Mondias Natural Products Inc. and changed its name to Lumiera Health Inc. in November 2020. Lumiera Health Inc. is based in Montreal, Canada.
Lumiera Health Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.